Nonionic detergent phase extraction for the proteomic analysis of heart membrane proteins using label-free LC-MS

Proteomics
Pamela M DonoghueMichael J Dunn

Abstract

Heart diseases resulting in heart failure are among the leading causes of morbidity and mortality in the Western world and can result from either systemic disease (e.g., hypertensive heart disease, ischemic heart disease) or specific heart muscle disease (e.g., dilated cardiomyopathy/DCM). Subproteome analysis of such disease subsets affords a reduction in sample complexity, potentially revealing biomarkers of cardiac failure that would otherwise remain undiscovered in proteome wide studies. Label-free nanoscale LC-MS has been applied in this study to validate a Triton X-114-based phase enrichment method for cardiac membrane proteins. Annotation of the subcellular location combined with GRAVY score analysis indicates a clear separation between soluble and membrane-bound proteins with an enrichment of over 62% for this protein subset. LC-MS allowed confident identification and annotation of hydrophobic proteins in this control sample pilot study and demonstrates the power of the proposed technique to extract integral membrane-bound proteins. This approach should be applicable to a wider scale study of disease-associated changes in the cardiac membrane subproteome.

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Nov 1, 1985·The Biochemical Journal·J M PercyD K Apps
May 5, 1982·Journal of Molecular Biology·J Kyte, R F Doolittle
Apr 29, 2000·Electrophoresis·V SantoniT Rabilloud
Apr 29, 2000·Electrophoresis·G L CorthalsJ C Sanchez
May 15, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·G M BoylanM C McElroy
Mar 1, 2003·Nature Biotechnology·Christine C Wu, John R Yates
Apr 15, 2003·Nature Biotechnology·Christine C WuJohn R Yates
May 2, 2003·Nature Biotechnology·Thierry Rabilloud
Apr 6, 2004·Advanced Drug Delivery Reviews·Ann M HopkinsAsma Nusrat
Apr 28, 2004·Journal of Molecular Biology·Lukas KällErik L L Sonnhammer
Sep 18, 2004·The Journal of Investigative Dermatology·Josip BlonderJonathan C Vogel
Nov 16, 2004·Proteomics·Angelika GörgMichael J Dunn
Dec 14, 2004·Proteomics·Pedro R CutillasRobert J Unwin
Apr 2, 2005·Analytical Chemistry·Jeffrey C SilvaScott Geromanos
Jun 15, 2005·Journal of Proteome Research·Sybille M N HuntMarc R Wilkins
Oct 11, 2005·Journal of Proteome Research·Natasha A KarpKathryn S Lilley
Oct 13, 2005·Molecular & Cellular Proteomics : MCP·Jeffrey C SilvaScott J Geromanos
Feb 18, 2006·Circulation Research·Emma McGregor, Michael J Dunn
Sep 22, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·James G CliftonDjuro Josic
Feb 13, 2007·Molecular & Cellular Proteomics : MCP·Johannes P C VissersJohannes M F G Aerts
Jun 7, 2007·Journal of Proteome Research·Graham W Horgan
Jul 27, 2007·Proteomics·Djuro Josic, James G Clifton
Jul 17, 2008·Comparative and Functional Genomics·John SkillingMark Ritchie

❮ Previous
Next ❯

Citations

May 10, 2011·Analytical and Bioanalytical Chemistry·Magnus WetterhallJonas Bergquist
Jul 23, 2011·Journal of Proteome Research·Lei ZhangMarcia M Miller
Nov 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Adrien JézégouBruno Gasnier
Feb 22, 2011·Circulation Research·Giulio AgnettiJennifer E Van Eyk
Feb 26, 2013·Molecular & Cellular Proteomics : MCP·Agnès ChapelAgnès Journet
Feb 12, 2013·Biochemistry·Kevin L ScheyJoshua J Nicklay
Apr 30, 2014·Revista Española De Cardiología·Javier Barallobre-BarreiroManuel Mayr
Jan 26, 2010·Journal of Proteomics·Andreas O HelbigMonique Slijper
Feb 1, 2011·Proteomics. Clinical Applications·Michaela D FiliouDaniel Martins-de-Souza
Apr 17, 2010·Journal of Proteomics·Chad M WarrenR John Solaro
Jul 28, 2019·The Journal of Membrane Biology·Kubra Karaosmanoglu YonetenErdal Karaoz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.